Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
09/16/2010 | US20100233153 Novel gene disruptions, compositions and the methods relating thereto |
09/16/2010 | US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof |
09/16/2010 | CA2755120A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
09/16/2010 | CA2754801A1 Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as dhodh inhibitor |
09/16/2010 | CA2754785A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
09/16/2010 | CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
09/16/2010 | CA2754589A1 Steroid compound |
09/15/2010 | EP2228435A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
09/15/2010 | EP2228434A1 Amplification method for hematopoietic stem cells with heterocyclic compound |
09/15/2010 | EP2228389A2 Antibodies against vascular endothelial growth factor 2 |
09/15/2010 | EP2228378A1 Monosebacate of pyrazole derivative |
09/15/2010 | EP2228060A1 Oral dosage forms comprising fenofibrate |
09/15/2010 | EP2227256A1 Method for treating bone fracture with anti-sclerostin antibodies |
09/15/2010 | EP2227242A2 Bone morphogenic protein binding peptide |
09/15/2010 | EP1536837B1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
09/15/2010 | EP1501819B1 Estrogen receptor modulators |
09/15/2010 | EP1250055B1 Immune modulation with death receptor-induced apoptosis |
09/15/2010 | CN1736466B Use of straw extract |
09/15/2010 | CN101835787A C2-C5-alkyl-imidazole-bisphosphonates |
09/15/2010 | CN101835770A Condensed compounds with activity at estrogen receptors |
09/15/2010 | CN101835501A Composition for treatment of joint disease |
09/15/2010 | CN101831435A Preparation and application of IL-15 isoform protein of mice |
09/15/2010 | CN101831004A Hyaluronic acid strontium salt compounds, preparation method thereof and application in medicine |
09/15/2010 | CN101830889A 嘧啶衍生物 Pyrimidine derivatives |
09/15/2010 | CN101830835A Sodium paeonol sulfonate crystalline hydrate as well as preparation method and application thereof |
09/15/2010 | CN101829313A Footbath effervescent tablet for improving rheumatic arthritis |
09/15/2010 | CN101829312A Medicament for treating rheumatoid arthritis and preparation method thereof |
09/15/2010 | CN101829311A Medicament for treating gonarthromeningitis and preparation method thereof |
09/15/2010 | CN101829291A Traditional Chinese medicine preparation for treating rheumatism and preparation method thereof |
09/15/2010 | CN101829283A Traditional Chinese medicine for treating lung cancer, gastric cancer, bone marrow cancer and metrocarcinoma and preparation method thereof |
09/15/2010 | CN101829265A Medicine composition for treating arthritis and gout, preparation method and preparation and application thereof |
09/15/2010 | CN101829264A Medicine composition for treating hyperuricemia and related diseases and preparation method and application thereof |
09/15/2010 | CN101829249A Traditional Chinese medicine powder for treating rheumatoid diseases |
09/15/2010 | CN101829224A Traditional Chinese medicine composition preparation and preparation method and quality control method |
09/15/2010 | CN101829215A External-use powder for treating burns, scalds and wound infections |
09/15/2010 | CN101829202A Traditional Chinese medicine composition for treating cervical vertebra pain and other diseases caused by cervical spondylosis |
09/15/2010 | CN101829174A Application of erigeron breviscapus extract in preparing anti-tumor or angiogenesis-suppressing medicaments, health-care food or cosmetics |
09/15/2010 | CN101829163A Application of rhizoma nardostachyos in preparing medicine for preventing and treating osteoporosis |
09/15/2010 | CN101829143A Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
09/15/2010 | CN101829125A Compound combined formulation for preventing and treating osteoarthrosis and preparation method thereof |
09/15/2010 | CN101829108A Application of diterpene ginkgolide |
09/15/2010 | CN101828771A Calcium carbide liquid health-care clothes |
09/15/2010 | CN101828720A Health food for reinforcing bone mineral density |
09/15/2010 | CN101371823B Technique for preparing double-acetyl emodic acid sustained-release capsules |
09/15/2010 | CN101361828B Medicine for treating scapulohumeral periarthritis and preparation method thereof |
09/15/2010 | CN101297853B Bone-melon extract injection and preparation thereof |
09/15/2010 | CN101269157B Method for preparing wine for warming meridian, removing paralysism, releasing tendon, activating collaterals to relieve pain |
09/15/2010 | CN101264160B Bone-setting and pain-relieving Chinese medicine composition and preparation thereof |
09/15/2010 | CN101181622B Method for preparing water extraction of white vein ointment |
09/15/2010 | CN101181355B Medicament for curing rheumatism and rheumatoid as well as preparation method thereof |
09/15/2010 | CN101156903B A externally used traditional Chinese medicine preparation for treating scapulohumeral periarthritis as well as its preparation method |
09/14/2010 | USRE41676 Intelligent serial battery charger and charging block |
09/14/2010 | US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest |
09/14/2010 | US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
09/14/2010 | US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
09/14/2010 | US7795023 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
09/14/2010 | US7795018 expresses CD14, CD34, CD45, type I collagen, and HLA-DR; differentiates into osteoblasts, skeletal myoblasts or chondrocytes; obtained by culturing peripheral blood mononuclear cells (PBMCs) in vitro on fibronectin; noninvasive; will not cause rejection at the time of cell transplantation |
09/14/2010 | US7794744 Nutritional modules |
09/14/2010 | US7794715 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions |
09/14/2010 | CA2441501C Rho-kinase inhibitors |
09/14/2010 | CA2434834C 6-substituted pyrido-pyrimidines |
09/14/2010 | CA2432009C Pharmaceutical preparations comprising a salt of an antibiotic and an antiphlogistic and use thereof |
09/14/2010 | CA2388342C Composition for restoring defects in calcified tissues |
09/14/2010 | CA2322792C Polypeptides homologous to vegf and bmp1 |
09/14/2010 | CA2320202C Agents and methods for protection, treatment and repair of connective tissue |
09/14/2010 | CA2222217C Use of fibroblast growth factors mutants to stimulate bone growth |
09/10/2010 | WO2010101537A1 Pharmaceutical composition of alendronate and a calcium salt combined in a single dosage form |
09/10/2010 | WO2010101192A1 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases |
09/10/2010 | WO2010101164A1 Pyridine derivative |
09/10/2010 | WO2010100431A1 Pyrrolopyrimidines used as kinase inhibitors |
09/10/2010 | WO2010100070A1 Inhibitors of bruton's tyrosine kinase |
09/10/2010 | WO2010050783A3 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same |
09/10/2010 | CA2754446A1 Pyridine derivative |
09/10/2010 | CA2753341A1 Inhibitors of bruton's tyrosine kinase |
09/10/2010 | CA2753236A1 Pyrrolopyrimidines used as kinase inhibitors |
09/09/2010 | US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
09/09/2010 | US20100227889 Benzimidazole Derivatives |
09/09/2010 | US20100227860 Disalt inhibitors of il-12 production |
09/09/2010 | US20100227859 Tricyclic compounds as matrix metalloproteinase inhibitors |
09/09/2010 | US20100227856 Novel compounds |
09/09/2010 | US20100227855 Helix 12 directed non-steroidal antiandrogens |
09/09/2010 | US20100227853 Inhibitors of cyclic amp phosphodiesterases |
09/09/2010 | US20100227845 Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
09/09/2010 | US20100227830 Use of escin |
09/09/2010 | US20100227824 Pharmaceutical peptides for the treatment of inflammatory diseases |
09/09/2010 | US20100227815 Site-specific pegylated linear salmon calcitonin analogues |
09/09/2010 | US20100227807 Use of Gelsolin to Diagnose and Treat Inflammatory Desease (Stossel) |
09/09/2010 | US20100227805 Molecules and Methods of Using Same for Treating CCR5/CCR5 Ligands Associated Diseases |
09/09/2010 | US20100227804 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier |
09/09/2010 | US20100227800 Triazole derivatives as kinase inhibitors |
09/09/2010 | US20100227354 Autoimmune Conditions and NADPH Oxidase Defects |
09/09/2010 | US20100227006 Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis |
09/09/2010 | US20100226996 Compositions and methods of delivery of pharmacological agents |
09/09/2010 | US20100226993 Composition for regenerative treatment of cartilage disease |
09/09/2010 | US20100226977 Low viscosity phospholipid compositions |
09/09/2010 | US20100226961 Cross-linked bioactive hydrogel matrices |
09/09/2010 | US20100226956 Production of moldable bone substitute |
09/09/2010 | US20100226928 Lyophilised Antibody Formulation |
09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
09/09/2010 | US20100226894 Mobilization of a complete cells mixture with embryonic like stem cells from the peripheral blood |